Application of Patient-Reported Outcome Measurements in Traditional Chinese Medicine Clinical Trials for Musculoskeletal Disorders in China: A Registry-Based Analysis
Evaluation & the Health Professions · 07.05.2026
DOI: 10.1177/01632787261444409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Evaluation & the Health Professions, online erschienen am 07.05.2026. Verfasst von Xuanyu Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing City, China. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine, The National Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
This study aimed to analyse the application characteristics of patient-reported outcomes (PROs) in traditional Chinese medicine (TCM) clinical trials for musculoskeletal disorders in China. This study included TCM clinical trials for musculoskeletal diseases conducted in China between January 1, 2010, and August 1, 2023. Data were extracted from ClinicalTrials.gov, the Chinese Clinical Registry, and the International Traditional Medicine Clinical Trial Registry. Eligible trials were categorized as (1) explicitly specified PROs, (2) implicitly specified PROs (generic outcome concepts [e.g., pain] without naming a specific instrument), and (3) PROs not mentioned. Of 494 eligible trials, 446 (90.3%) used PROs as endpoints. Of 67,839 participants, 58,093 (85.6%) were in trials with specific PRO tools, 4,400 (6.5%) in trials with ambiguous PRO descriptions, and 5,346 (7.9%) in trials without PROs. Arthropathies (43.0%) were the most common condition among PRO-inclusive trials, and the Visual Analogue Scale was the most frequently used PRO tool. Primary sponsors showed significant regional imbalance, with most concentrated in eastern China. This study demonstrated a significant emphasis on PRO application in TCM clinical trials for musculoskeletal diseases in China, while also identifying gaps in standardization and regional distribution that require addressing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing City, China.
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing City, China.
- Center for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing City, China.
- Institute for Excellence in Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing City, China.
ORCID-Profile: Yansong Zhao
Förderung
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
- The National Administration of Traditional Chinese Medicine
Zitieren
APA
Chen, X., Gong, Y., Lin, Y., Rong, H., & Zhao, Y. (2026). Application of Patient-Reported Outcome Measurements in Traditional Chinese Medicine Clinical Trials for Musculoskeletal Disorders in China: A Registry-Based Analysis. Evaluation & the Health Professions. https://doi.org/10.1177/01632787261444409
Vancouver
Chen X, Gong Y, Lin Y, Rong H, Zhao Y. Application of Patient-Reported Outcome Measurements in Traditional Chinese Medicine Clinical Trials for Musculoskeletal Disorders in China: A Registry-Based Analysis. Evaluation & the Health Professions. 2026. doi:10.1177/01632787261444409
BibTeX
@article{Chen2026,
author = {Chen, Xuanyu and Gong, Yijia and Lin, Yuanyuan and Rong, Hongguo and Zhao, Yansong},
title = {Application of Patient-Reported Outcome Measurements in Traditional Chinese Medicine Clinical Trials for Musculoskeletal Disorders in China: A Registry-Based Analysis},
journal = {Evaluation & the Health Professions},
year = {2026},
doi = {10.1177/01632787261444409}
}
EUVIMED